Temat: tumours - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Octreotide LAR in neuroendocrine tumours – a summary of the experience
Autorzy:: Kolasińska-Ćwikła, Agnieszka
Powiązania:: https://bibliotekanauki.pl/articles/1061844.pdf
Data publikacji:: 2017
Wydawca:: Medical Education
Tematy:: neuroendocrine tumours
octreotide LAR
somatostatin analogues
Opis:: Neuroendocrine tumours are a rare and heterogeneous group of neoplasms. Most of the patients are diagnosed with locally advanced or metastatic disease and curative surgery is rarely an option. Somatostatin analogues have been shown to control the symptoms and growth of well-differentiated metastatic neuroendocrine tumours. Octreotide LAR is one of the treatment options.
Źródło:: OncoReview; 2017, 7, 1; 22-27
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: The mTOR signalling pathways in the pathogenesis and treatment of neuroendocrine tumours
Autorzy:: Kolasińska-Ćwikła, Agnieszka
Powiązania:: https://bibliotekanauki.pl/articles/1064993.pdf
Data publikacji:: 2016
Wydawca:: Medical Education
Tematy:: mTOR inhibitors
mTOR signalling pathway
neuroendocrine tumours (NETs)
Opis:: Neuroendocrine tumours (NET) are a rare and heterogeneous group of neoplasms. The majority of patients are diagnosed with locally advanced or metastatic disease, and curative surgery is rarely an option. Treatment approaches involving targeted therapy, including the use of agents inhibiting the mTOR signalling pathways involved in neuroendocrine tumourigenesis, provide new therapeutic options for patients with NETs.
Źródło:: OncoReview; 2016, 6, 1; A37-42
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Challenges in diagnosing and treating pancreatic neuroendocrine tumours in patients with a multiple endocrine neoplasia type 1 (MEN1) syndrome
Autorzy:: Rogozik, Natalia
Kolasińska-Ćwikła, Agnieszka
Ćwikła, Jarosław B.
Cichocki, Andrzej
Przybyłkowski, Adam
Słodkowski, Maciej
Bednarczuk, Tomasz
Powiązania:: https://bibliotekanauki.pl/articles/1035818.pdf
Data publikacji:: 2018
Wydawca:: Medical Education
Tematy:: diagnosis
multiple endocrine neoplasia type 1 syndrome
pancreatic neuroendocrine tumours
treatment
Opis:: Multiple endocrine neoplasia type 1 (MEN1) syndrome is an autosomal dominant hereditary disorder characterised by coexistence of pancreatic neuroendocrine tumours (pNETs) with parathyroid and pituitary tumours. PNETs, including mostly non-functioning tumours, gastrinoma and insulinoma, occur in nearly 95% of MEN1 patients and account for over 50% of disorder-related mortality. Therefore, early initiation of screening for pNET using biochemical and imaging tests as well as appropriate surgical and systemic treatment are of particular importance for this group of patients. Currently, there are no clearly defined guidelines which determine the optimal methods for detection and treatment of pNET in MEN1. Caution should be exercised when applying the guidelines designed for patients with sporadic pNET to MEN1 patients as the clinical course of the disorder is slightly different, involving multifocality of lesions and younger age of patients at onset. This paper discusses the distinctive features and challenges in diagnosing and treating pNETs in MEN1 patients.
Źródło:: OncoReview; 2018, 8, 2; 42-47
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "tumours" wg kryterium: Temat

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język